The loss of Neu5Gc in humans may have contributed to resistance to generalist pathogens and increased pathogenicity of human-specific pathogens. Human-specific cholera, which employs host sialic acids to trigger a gastrointestinal response, preferentially uses Neu5Ac and is inhibited by Neu5Gc.
